HomeCompareTBRIF vs KMB

TBRIF vs KMB: Dividend Comparison 2026

TBRIF yields 5263.16% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TBRIF wins by $102432968530093.38M in total portfolio value
10 years
TBRIF
TBRIF
● Live price
5263.16%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102432968530093.42M
Annual income
$98,742,385,398,383,070,000.00
Full TBRIF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — TBRIF vs KMB

📍 TBRIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTBRIFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TBRIF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TBRIF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TBRIF
Annual income on $10K today (after 15% tax)
$447,368.42/yr
After 10yr DRIP, annual income (after tax)
$83,931,027,588,625,610,000.00/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, TBRIF beats the other by $83,931,027,588,625,610,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TBRIF + KMB for your $10,000?

TBRIF: 50%KMB: 50%
100% KMB50/50100% TBRIF
Portfolio after 10yr
$51216484265046.73M
Annual income
$49,371,192,699,191,530,000.00/yr
Blended yield
96.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

TBRIF
No analyst data
Altman Z
-175.5
Piotroski
3/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TBRIF buys
0
KMB buys
0
No recent congressional trades found for TBRIF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTBRIFKMB
Forward yield5263.16%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$102432968530093.42M$45.9K
Annual income after 10y$98,742,385,398,383,070,000.00$5,222.34
Total dividends collected$102183681196311.97M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: TBRIF vs KMB ($10,000, DRIP)

YearTBRIF PortfolioTBRIF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$537,016$526,315.79$11,314$614.45+$525.7KTBRIF
2$26,989,550$26,414,942.92$12,867$760.19+$26.98MTBRIF
3$1,269,600,822$1,240,722,003.32$14,713$945.27+$1269.59MTBRIF
4$55,904,391,573$54,545,918,693.73$16,924$1,181.90+$55904.37MTBRIF
5$2,304,512,049,686$2,244,694,350,703.24$19,596$1,486.64+$2304512.03MTBRIF
6$88,943,998,518,419$86,478,170,625,254.53$22,850$1,882.16+$88943998.50MTBRIF
7$3,214,493,329,356,589$3,119,323,250,941,881.00$26,849$2,399.80+$3214493329.33MTBRIF
8$108,798,712,659,598,690$105,359,204,797,187,140.00$31,812$3,083.36+$108798712659.57MTBRIF
9$3,449,143,113,747,977,000$3,332,728,491,202,206,700.00$38,033$3,994.72+$3449143113747.94MTBRIF
10$102,432,968,530,093,420,000$98,742,385,398,383,070,000.00$45,918$5,222.34+$102432968530093.38MTBRIF

TBRIF vs KMB: Complete Analysis 2026

TBRIFStock

Therma Bright Inc. engages in the development and sale of rapid COVID testing products, medical devices for pain management, devices to improve circulation, and devices for the cosmeceutical industry. The company's products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; Venowave, a medical compression pump designed to treat and alleviate the symptoms associated with poor circulation; and TherOZap, a thermal therapy insect device that reduces the inflammatory response, as well as relieves the symptoms of pain, itching, and inflammation associated with insect bites and stings. It serves consumers and medical professionals. The company was formerly known as The Jenex Corporation and changed its name to Therma Bright Inc. in February 2018. Therma Bright Inc. was incorporated in 2001 and is based in Toronto, Canada.

Full TBRIF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this TBRIF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TBRIF vs SCHDTBRIF vs JEPITBRIF vs OTBRIF vs KOTBRIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.